Introduction
Cancer remains the second leading cause of death all over the world [1] . Cancer chemotherapy is generally accompanied by side effects. If an anticancer drug could be delivered only to the right site in the right concentration at the right time, cancer could be cured without any side effects [2] [3] . Thus, anticancer and antitumor properties of products have great importance.
Perylene diimide derivatives have been widely studied as G-quadruplex interactive compounds and telomerase inhibitors. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . Gquadruplexes are unusual DNA secondary structures based on planes of four guanines (G-tetrads) stabilized by Hoogsteen G-G pairings and monovalent cations. The central aromatic core of the perylene diimides is suitable for π-π stacking interactions with the terminal G-tetrad of DNA Gquadruplex, while the hydrophilic side chains interact with the DNA grooves. By means of these two kinds of interactions, these molecules are able to induce and stabilize G-quadruplex structures in G-rich singlestranded Oligonucleotides. This is of great pharmaceutical interest, since the terminal ends of eukaryotic chromosomes (telomeres) are characterized by the presence of a single-stranded G-rich overhang that represents the substrate of a reverse transcriptase enzyme, the ribonucleoprotein telomerase, which is involved in the maintenance of telomere length. This enzyme is not active in most somatic cells but is active in most human tumors, and is, therefore, considered as being of high potential as a selective target for different antitumor strategies [4] . Several investigators have experimentally observed that if an 125 I radionuclide is incorporated into the nucleus of a cell, it results in a high radiotoxic effectiveness when its decay occurs [14] [15] . The same authors have also demonstrated that this radiotoxicity of 125 I becomes more effective when 125 I decay occurs in the structure of DNA or very close to it. This extreme radiotoxicity is at least 10 times greater than that of other radionuclides such as 131 I, 14 C, or 3 H [16] . In the case of the combination of radiolabeled perylene diimide with the high radiotoxicity of an appropriate radionuclide such as 125 I, Auger and/or α-emitting radionuclides, it is expected that a very effective radiolabeled anti-cancer drug can be designed, which will have large potential applications in cancer therapy. In addition, in the case of labeling this drug with an appropriate radionuclide, this may similarly be used for early diagnosis of some kinds of tumors.
One of the more novel and beneficial application of singlet oxygen in medicine is the cure of tumors. Today, photodynamic therapy (PDT) has become a potential candidate for the major utilization in the modern operation of cancer. Targeted photodynamic therapy is a new strategy that aims to direct the photosensitizers specifically towards the tumor tissues to enhance the efficiency and specificity of PDT [17] . Starting from this consideration, PDI-Pyr (N-(2,6-diisopropylphenyl)-Nʹ-(3-carboxy-2-pyridyl)-1,7-bis{4-[(4-pyrene-1-ylbutanoyl)oxy]phenoxy}perylene-3,4,9,10-tetracarboxylicdiimide) which was considered as an anti-cancer drug was synthesized and subjected to radioiodination, and its biological activities in the metabolism of rats were examined for preliminary testing of the anti-cancer potential of PDI-Pyr (Fig. 1) .
As a result, it is hoped that PDI-Pyr will be able to be used as an appropriate carrier for selective incorporation of radioactive iodine atoms into the nucleus of tumor cells, and in addition, the radiotoxicity, for example, of 125 I can be realized on the same agent, which will be used as an effective anti-cancer drug for cancer types. Thus, the overall aim of this work was to design of a new anti-cancer drug.
Material and Methods
Preparing the iodogen coated tubes 1 mg amount of iodogen was dissolved in CH 2 CI 2 and transferred to closed tubes. CH 2 CI 2 was evaporated by air flow and iodogen was deposited on the walls of glass tubes as a thin film. These tubes were stored at +4 °C until use.
Radioiodination procedure
PDI-Pyr was radioiodinated with 131 I using the iodogen method under the same conditions as earlier described by Avcıbaşı et al [18] [19] [20] [21] . In order to label PDI-Pyr with 131 I, 100 μg of PDI-Pyr was added into the iodogen coated tube and then 1mCi (37 MBq) of Na 131 I was added. This reaction mixture was kept at room temperature without stirring for 15 min. At the end of this time, the mixture was transferred to another tube by a syringe, and then quality control was performed.
TLRC Studies
For TLRC studies, TLC Aluminum sheets (Merck, 20×20 cm code: 5552) were used, and citric acid monohydrate (100%, pH:6) was used as the mobile phase. The TLRC technique was used to determine the R f values of the radioiodinated products. Each TLRC sheet was covered by an adhesive band after its development and was cut into 0.5 cm width. Those pieces of TLRC were then counted by using a Cd(Te) detector equipped with a RAD 501 singlechannel analyzer. The R f values were determined and given in Tables 1.
Scintigraphic Studies
The imaging studies were performed on healthy male Albino Wistar rats using a gamma camera (Infinia, GE, Tirat Hacermel, Israel) at Department of Nuclear Medicine of Celal Bayar University. 
Results

Results of TLRC Studies
The results of TLRC studies showed that citric acid mono hydrate, 100%, was the most suitable developing solvent to establish their R f values given in Table 1 . The best labeling yield was obtained at about 97% when the pH value was set to 6. Radiochromatograms of 131 I-PDI-Pyr was given in Fig. 2 .
Results of Scintigraphy Studies
After administration of 131 I-PDI-Pyr and Na 131 I to rats, static and dynamic scintigrams were obtained. Fig. 3 and 5 show the dynamic images of 131 I-PDI-Pyr and Na 131 I, respectively. Fig. 4 and 6 show the static images corresponding to 30, 60 and 120 min after the administrations of these compounds. Table 1 and 2 also showed organ/background (BG) ratios of 131 I-PDI-Pyr and Na 131 I. As seen dynamic scintigrams of 131 I-PDI-Pyr, it was clearly observed that there were an important accumulation in the abdominal and the chest zone. 131 I-PDI-Pyr was significantly localized in the stomach within 30 min. Another result of dynamic images of related compound was the presence of high uptake in the heart, the lung and the liver. As seen dynamic scintigrams of Na 131 I, it was clearly seen that metabolism of Na 131 I was completely different from that of 131 I-PDI-Pyr. Na 131 I was highly accumulated in the stomach and the bladder after the administration within 1-2 min. There was a high accumulation in the bladder in the 30 min.
In the static images of the 131 I-PDI-Pyr, activities mentioned above were seemed to be increased at 120 min. Accumulation in these zones could probably be caused by the increased specificities of the drug into the liver, the lung, the stomach and the bladder. Similar results were obtained from a pyridine substituted PDI derivative which was radioiodinated with 131 I, and this product was accumulated in the stomach of a male Albino Wistar rats over about 30 minutes [22] . Organ/background (BG) ratios of 131 I-PDI-Pyr and Na 131 I were given in Table 2 At the next step of this study, the selective incorporation of 125 I-PDI-Pyr into some cancer cells should be examined using tumor bearing laboratory animals or cultured cancer cell lines. 
